Regarding chemerin’s role in chronic pancreatitis, Adrych et al. [45] first reported increased serum chemerin levels in patients with chronic pancreatitis, independent of diabetes or BMI reduction, suggesting that chemerin reflects local inflammatory and fibrogenic activity rather than adiposity. Here, RARRES2 is linked to diabetes mellitus.